GATA4-NKX2-5-IN-1 NEW
Price | $56 | $137 | $188 |
Package | 1mg | 5mg | 10mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-11 |
Product Details
Product Name: GATA4-NKX2-5-IN-1 | CAS No.: 544681-96-1 |
Purity: 99.00% | Supply Ability: 10g |
Release date: 2024/11/11 |
Product Introduction
Bioactivity
名稱 | GATA4-NKX2-5-IN-1 |
描述 | GATA4-NKX2-5-IN-1 exhibits no activity on the protein kinases involved in the regulation of GATA4 phosphorylation, and it modulates the hypertrophic agonist-induced cardiac gene expression.GATA4-NKX2-5-IN-1 ?dose-dependently inhibits the GATA4–NKX2-5 transcriptional synergy with an IC50 of 3 μM. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 65 mg/ml (186.02 mM) |
關鍵字 | GATA4 NKX2 5 IN 1 | inhibit | GATA-4-NKX2-5-IN-1 | Inhibitor | GATA4-NKX2-5-IN-1 | GATA4NKX25IN1 |
相關庫 | 經(jīng)典已知活性庫 | 抑制劑庫 | 已知活性化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$2580.00/50mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-28 | |
$70.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-06-05 | |
$56.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-11 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY